|
Melero-Amor, A; Garcia-Candel, F; Atucha, NM; Romecin, P; Bernal, DG; Iyu, D; Millan, JE; Moraleda, JM. Study of platelet function in hemophilia a in the region of murcia. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2015; 13:931-931.
AÑO: 2015; IF: 5.824
|
|
Glenn JR, White AE, Iyu D, Heptinstall S. PGE(2) reverses G(s)-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-G(s)-mediated inhibition of platelet aggregation by interaction with EP4 receptors. Platelets. 2012;23(5):344-51. doi: 10.3109/09537104.2011.625575. Epub 2012 Mar 21. PubMed PMID: 22436052.
AÑO: 2012; IF: 2.24
|
|
Iyú D, Glenn JR, White AE, Johnson A, Heptinstall S, Fox SC. The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function. Thromb Haemost. 2012 Apr;107(4):797-9. doi: 10.1160/TH11-11-0794. Epub 2012 Feb 8. PubMed PMID: 22318645.
AÑO: 2012; IF: 6.094
|
|
Iyú D, Glenn JR, White AE, Fox SC, Dovlatova N, Heptinstall S. P2Y?? and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP. Platelets. 2011;22(7):504-15. doi: 10.3109/09537104.2011.576284. Epub 2011 May 19. PubMed PMID: 21591981.
AÑO: 2011; IF: 1.847
|
|
Iyú D, Glenn JR, White AE, Fox SC, Heptinstall S. Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist. Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):416-22. doi: 10.1161/ATVBAHA.110.219501. Epub 2010 Nov 24. PubMed PMID: 21106949.
AÑO: 2011; IF: 6.368
|